News & Press Releases

CELLERANT THERAPEUTICS AWARDED $153 MILLION CONTRACT BY BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO DEVELOP TREATMENT FOR ACUTE RADIATION SYNDROME (ARS)
September 1, 2010

 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.